Overweight/obesity
Drug research and approvals for overweight/obesity: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 1,355 studies of overweight/obesity are recruiting on ClinicalTrials.gov, and Health Canada has authorized 66 drug trials for it since 2013.
- Recruiting worldwide: 1,355
- Trials authorized in Canada: 66
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 1,355 recruiting on ClinicalTrials.gov ↗- The Effect of Oral Iron Supplements on Insulin and Glucose Metabolism in Overweight and Obese WomenNCT07315282 · Not applicable · Nicole Stoffel · starts May 1, 2027
- Stanford Healthy Goals StudyNCT07839832 · Not applicable · Stanford University · starts Jan 1, 2027
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine,…NCT07083557 · Not reported · Bettina Mittendorfer · starts Jan 1, 2027
- Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion DysregulationNCT07607730 · Not applicable · Children's Mercy Hospital Kansas City · starts Jan 1, 2027
- Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular DystrophyNCT07642635 · Phase 1 / Phase 2 · Vanderbilt University Medical Center · starts Dec 1, 2026
- Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With…NCT07908316 · Phase 1 · Amgen · starts Nov 13, 2026
- BRE-13: Mediterranean DietNCT07869355 · Not applicable · University of Illinois Chicago · starts Nov 11, 2026
- Whole-Body Vibration Training in Women With Obesity With and Without Type 2 DiabetesNCT07924436 · Not applicable · Pamukkale University · starts Nov 9, 2026
- Mediterranean Longevity Diet and Fasting Mimicking Diet in Adolescents With Overweight or ObesityNCT07938268 · Not applicable · Fondazione Valter Longo · starts Nov 3, 2026
- Pharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Varying Degrees of Renal…NCT07938515 · Phase 1 · Chendu DIAO Pharmaceutical Group CO., LTD. · starts Nov 2, 2026
Trials Authorized in Canada
The 10 newest of 66; search them all in Canada trials| Nov 5, 2026 | An investigation of the effect of subcutaneous zenagamtide on pharmacokinetics of an oral combination contraceptive (ethinylestradiol and levonorgestrel) and…ZENAGAMTIDE (NNC0487-0111) / PORTIA (ETHINYL ESTRADIOL / LEVONORGESTREL) /… | Novo Nordisk | Pending |
| Sep 14, 2026 | A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of once-weekly berobenatide in adults with knee osteoarthritis…BEROBENATIDE (PF-08653944) | Pfizer | Pending |
| Aug 25, 2026 | A phase 2, randomized, double-blind, placebo-controlled, parallel-group 52 week trial to investigate the efficacy and safety of olatorepatide, a glp-1/gip…OLATOREPATIDE (HS-20094) | Regeneron | Pending |
| Aug 20, 2026 | A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of once-monthly berobenatide in adults with knee osteoarthritis…BEROBENATIDE (PF-08653944, MET097) | Pfizer | Pending |
| Aug 20, 2026 | A phase III, randomized, double-blind, placebo controlled, parallel group study to evaluate the efficacy and safety of once weekly petrelintide vs. placebo in…PETRELINTIDE (RO7895515) | Roche | Pending |
| Aug 20, 2026 | A phase III, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of once weekly petrelintide vs. placebo in…PETRELINTIDE (RO7895515) | Roche | Pending |
| Aug 20, 2026 | A phase III, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of once weekly petrelintide vs. placebo in…PETRELINTIDE (RO7895515) | Roche | Pending |
| Aug 6, 2026 | Zenagamtide use for the reduction of risk of major adverse cardiovascular events in people with established atherosclerotic cardiovascular disease and either…ZENAGAMTIDE INJECTION | Novo Nordisk | Ongoing |
| Aug 5, 2026 | A phase 3, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of once-weekly eloralintide in adult participants with…ELORALINTIDE (LY3841136) | Eli Lilly | Pending |
| Jul 23, 2026 | A phase III randomised, double-blind, placebo-controlled multicentre trial to evaluate the efficacy and safety of azd6234 as an adjunct to incretin-based…LENBELINTIDE (AZD6234) | AstraZeneca Pharmaceuticals LP | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA